Pune: Serum Institute of India (SII) has sought approval from Drugs Controller General of India (DCGI) for Covishield to be administered in the form of booster dose.
In an application to drugs regulator DCGI, Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute, has cited adequate vaccine stock in India and a necessity for a booster shot especially after the emergence of new coronavirus variants, PTI reported quoting sources.
SII further mentioned that UK’s Medicines and Healthcare products Regulatory Agency has already approved booster dose of Oxford-AstraZeneca’s ChAdOx1 nCoV-19 vaccine. Since Serum Institute is manufacturing the same vaccine in a different brand name (Covishield), it’s only logical that India should embrace it.
Also Read: Omicron-Specific Booster Shot Possible, Says Adar Poonawala
Unlike countries like the US, UK, Germany, India has not decided on introducing a booster shot for its citizens. But a decision on the matter may be announced soon.
Also Read: COVID Vaccine: Policy On Booster & Additional Dose To Be Made Public In 2 Weeks
Bhubaneswar: The Odisha Human Rights Commission (OHRC) has sent notices to Secretaries of Food &…
New Delhi: Even as his recently-released horror comedy ‘Bhool Bhulaiyaa 3’ continues to mint money…
New Delhi/Bhubaneswar: After over 20 days of investigation and analysing more than 700 CCTV cameras,…
New Delhi: The Delhi High Court has closed proceedings on a petition challenging the Rajiv…
Mumbai: ‘12th Fail’ actor Vikrant Massey recently got trolled after pictures of him touching his…
Mumbai: Mumbai Police swung into action immediately after Bollywood superstar Shah Rukh Khan received a…
Dubai: The effects of global climate change are being seen in various manifestations across the globe.…
Mumbai: When criminals are idolised and used for commercial purposes, police are bound to take action.…